FrancophonIA/ELRC3.0 huggingface dataset:
English: Nervous system disorders During monotherapy clinical trials: Very common:
Slovenian: Klinična preskušanja z monoterapijo: Zelo pogosti:
English: Lamictal and associated names (see Annex I) 200 mg tablets.
Slovenian: Lamictal in sorodna imena (glejte Prilogo I) 200 mg tablete.
English: 1 − 5 mg/kg/day (once a day or two divided doses)
Slovenian: 1 - 5 mg/kg/dan (enkrat na dan ali v dveh deljenih odmerkih)
English: 200 mg Dispersible/Chewable Tablets
Slovenian: 200 mg Disperzibilne/žvečljive tablete
English: 200 mg dispersible/chewable tablets:
Slovenian: 200 mg disperzibilne/žvečljive tablete:
English: White to off-white multi-faceted, super-elliptical, tablet with a blackcurrant odour, marked “GSCX7” on one side and “50” on the other.
Slovenian: Bele do umazano bele večkotne, supereliptične tablete z vonjem po črnem ribezu, označene z "GSCX7" na eni strani in "50" na drugi.
English: BOTTLE
Slovenian: Placebo
English: Each pack contains blisters of 14, 30, 42, 56, 90 or 100 tablets.
Slovenian: Eno pakiranje vsebuje pretisne omote s 14, 30, 42, 56, 90 ali 100 tabletami.
English: 2 mg dispersible/chewable tablets:
Slovenian: 2 mg disperzibilne/žvečljive tablete:
English: Pale, yellowish-brown, multifaceted, super-elliptical tablet, marked “GSEE5” on one side and “100” on the other.
Slovenian: Bledo rumeno-rjave, večkotne, supereliptične tablete z oznako "GSEE5" na eni in "100" na drugi strani.
English: Each Lamictal 100 mg dispersible/chewable tablet contains 100 mg lamotrigine.
Slovenian: Ena disperzibilna/žvečljiva tableta Lamictal 100 mg vsebuje 100 mg lamotrigina.
English: HDPE bottles with a child resistant/tamper evident closure.
Slovenian: Stekleničke iz HDPE z zaščitno/za otroke varno zaporko Pakiranja s 30 disperzibilnimi/žvečljivimi tabletami.
English: 25 mg dispersible/chewable tablets:
Slovenian: 25 mg disperzibilne/žvečljive tablete:
English: 5 mg dispersible/chewable tablets:
Slovenian: 5 mg disperzibilne/žvečljive tablete:
English: HOW TO STORE LAMICTAL
Slovenian: SHRANJEVANJE ZDRAVILA LAMICTAL
English: Caution should be exercised when administering Lamictal to patients with renal failure.
Slovenian: Pri bolnikih z ledvično odpovedjo morate Lamictal uporabljati previdno.
English: Strength Pharmaceutical form
Slovenian: Farmacevtska oblika Pot uporabe
English: Lamictal and associated names (see Annex I) 100 mg dispersible/chewable tablets.
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 100 mg disperzibilne/žvečljive tablete.
English: Each pack contains blisters of 30, 50, 56, 60, 90 or 100 tablets.
Slovenian: Eno pakiranje vsebuje pretisne omote s 30, 50, 56, 90 ali 100 tabletami.
English: 2 mg Dispersible/Chewable Tablets
Slovenian: 2 mg Disperzibilne/žvečljive tablete
English: Lamictal and associated names (see Annex I) 25 mg dispersible/chewable tablets.
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 25 mg disperzibilne/žvečljive tablete.
English: 100 mg dispersible/chewable tablets:
Slovenian: 100 mg disperzibilne/žvečljive tablete:
English: Lamictal 200 mg dispersible/chewable tablets are square with rounded corners.
Slovenian: Lamictal 200 mg disperzibilne/žvečljive tablete so kvadratne oblike in imajo zaobljene vogale.
English: 25 mg Dispersible/Chewable Tablets
Slovenian: 25 mg Disperzibilne/žvečljive tablete
English: Each Lamictal 25 mg dispersible/chewable tablet contains 25 mg lamotrigine.
Slovenian: Ena disperzibilna/žvečljiva tableta Lamictal 25 mg vsebuje 25 mg lamotrigina.
English: General disorders and administration site conditions During bipolar disorder clinical trials: Common:
Slovenian: Splošne težave in spremembe na mestu aplikacije Klinična preskušanja pri bipolarni motnji: Pogosti:
English: Lamictal and associated names (see Annex I) 200 mg dispersible/chewable tablets.
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 200 mg disperzibilne/žvečljive tablete.
English: 50 mg dispersible/chewable tablets:
Slovenian: 50 mg disperzibilne/žvečljive tablete:
English: Nervous system disorders During bipolar disorder clinical trials: Very common:
Slovenian: Klinična preskušanja pri bipolarni motnji: Zelo pogosti:
English: Lamictal 100 mg dispersible/chewable tablets are square with rounded corners.
Slovenian: Lamictal 100 mg disperzibilne/žvečljive tablete so kvadratne oblike in imajo zaobljene vogale.
English: Steady-state trough plasma concentrations of lamotrigine were not affected by concomitant pregabalin (200 mg, 3 times daily) administration.
Slovenian: Sočasna uporaba pregabalina (200 mg 3-krat na dan) ni vplivala na plazemsko koncentracijo lamotrigina v stanju dinamičnega ravnovesja.
English: Check with your doctor or pharmacist if you're not sure.
Slovenian: Če ste negotovi, se posvetujte z zdravnikom ali farmacevtom.
English: Pregnancy may also alter the effectiveness of Lamictal, so your doctor may take samples of your blood to check the level of Lamictal, and may adjust your dose.
Slovenian: Zato vas bo zdravnik morda napotil na preglede krvi, da bo preveril koncentracijo zdravila Lamictal.
English: Lamictal and associated names (see Annex I) 2 mg dispersible/chewable tablets.
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 2 mg disperzibilne/žvečljive tablete.
English: 200 mg Dispersible or chewable Tablet
Slovenian: 200 mg Disperzibilna ali žvečljiva tableta
English: STATEMENT OF ACTIVE SUBSTANCE Each tablet contains 100 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena tableta vsebuje 100 mg lamotrigina.
English: 100 mg Dispersible/Chewable Tablets
Slovenian: 100 mg Disperzibilne/žvečljive tablete
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 100 mg dispersible/chewable tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 100 mg disperzibilne/žvečljive tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: White to off-white multi-faceted, super-elliptical, tablet with a blackcurrant odour, marked “GSCL5” on one side “25” on the other.
Slovenian: Bele do umazano bele večkotne, supereliptične tablete z vonjem po črnem ribezu, označene z "GSCL5" na eni strani in "25" na drugi.
English: 5 mg Dispersible/Chewable Tablets
Slovenian: 5 mg Disperzibilne/žvečljive tablete
English: Lamictal and associated names (see Annex I) 50 mg dispersible/chewable tablets.
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 50 mg disperzibilne/žvečljive tablete.
English: STATEMENT OF ACTIVE SUBSTANCE Each tablet contains 200 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena tableta vsebuje 200 mg lamotrigina.
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 200 mg dispersible/chewable tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 200 mg disperzibilne/žvečljive tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: STATEMENT OF ACTIVE SUBSTANCE Each dispersible/chewable tablet contains 100 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena disperzibilna/žvečljiva tableta vsebuje 100 mg lamotrigina.
English: Lamictal 25 mg dispersible/chewable tablets are square with rounded corners.
Slovenian: Lamictal 25 mg disperzibilne/žvečljive tablete so kvadratne oblike in imajo zaobljene vogale.
English: 50 mg Dispersible/Chewable Tablets
Slovenian: 50 mg Disperzibilne/žvečljive tablete
English: Lamictal and associated names (see Annex I) 5 mg dispersible/chewable tablets.
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 5 mg disperzibilne/žvečljive tablete.
English: Each Lamictal 50 mg dispersible/chewable tablet contains 50 mg lamotrigine.
Slovenian: Ena disperzibilna/žvečljiva tableta Lamictal 50 mg vsebuje 50 mg lamotrigina.
English: Unless safety concerns (for example rash) require an abrupt withdrawal, the dose of Lamictal should be gradually decreased over a period of two weeks.
Slovenian: Odmerek Lamictala je treba zniževati postopoma v obdobju dveh tednov, razen v primerih, ko je treba zdravilo zaradi varnosti (npr. izpuščaja) opustiti na hitro.
English: Gastrointestinal disorders During bipolar disorder clinical trials: Common:
Slovenian: Klinična preskušanja pri bipolarni motnji: Pogosti:
English: Major depressive episode
Slovenian: Merilo za vključitev hujša depresivna epizoda hujša manična epizoda
English: STATEMENT OF ACTIVE SUBSTANCE Each tablet contains 50 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena tableta vsebuje 50 mg lamotrigina.
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 2 mg dispersible/chewable tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 2 mg disperzibilne/žvečljive tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: Lamictal 50 mg dispersible/chewable tablets are square with rounded corners.
Slovenian: Lamictal 50 mg disperzibilne/žvečljive tablete so kvadratne oblike in imajo zaobljene vogale.
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 100 mg tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 100 mg tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: STATEMENT OF ACTIVE SUBSTANCE Each tablet contains 25 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena tableta vsebuje 25 mg lamotrigina.
English: 25 mg Dispersible or chewable Tablet
Slovenian: 25 mg Disperzibilna ali žvečljiva tableta
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 25 mg dispersible/chewable tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 25 mg disperzibilne/žvečljive tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 25 mg tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 25 mg tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: 100 mg Dispersible or chewable Tablet
Slovenian: 100 mg Disperzibilna ali žvečljiva tableta
English: 5 mg Dispersible or chewable Tablet
Slovenian: 5 mg Disperzibilna ali žvečljiva tableta
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Slovenian: Izgled tablet Lamictal in vsebina pakiranja
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 50 mg dispersible/chewable tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 50 mg disperzibilne/žvečljive tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 5 mg dispersible/chewable tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 5 mg disperzibilne/žvečljive tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 200 mg tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 200 mg tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: NAME OF THE MEDICINAL PRODUCT Lamictal and associated names (see Annex I) 50 mg tablets [See Annex I - To be completed nationally] Lamotrigine
Slovenian: Lamictal in sorodna imena (glejte Dodatek I) 50 mg tablete [Glejte Dodatek I - Izpolni država članica] lamotrigin
English: Î See a doctor as soon as possible or go to the nearest hospital for help.
Slovenian: Če opazite katerega izmed teh simptomov: Î Čim prej pojdite k zdravniku.
English: Lot
Slovenian: KG
English: 50 mg Dispersible or chewable Tablet
Slovenian: 50 mg Disperzibilna ali žvečljiva tableta
English: Prescribers should assess the need for escalation to maintenance dose when restarting Lamictal in patients who have discontinued Lamictal for any reason, since the risk of serious rash is associated with high initial doses and exceeding the recommended dose escalation for lamotrigine (see section 4.4).
Slovenian: Tveganje za resen izpuščaj je namreč povezano z visokimi začetnimi odmerki in s prekoračenjem priporočenega zviševanja odmerka lamotrigina (glejte poglavje 4.4).
English: STATEMENT OF ACTIVE SUBSTANCE Each dispersible/chewable tablet contains 25 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena disperzibilna/žvečljiva tableta vsebuje 25 mg lamotrigina.
English: STATEMENT OF ACTIVE SUBSTANCE Each dispersible/chewable tablet contains 2 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena disperzibilna/žvečljiva tableta vsebuje 2 mg lamotrigina.
English: (Starter pack 42 tablets, non-valproate add-on therapy - calender pack showing day numbers): 1 2 3 4 5 6 7 (1 pocket)
Slovenian: (Začetno pakiranje z 42 tabletami, dodatek zdravljenja brez valproata - koledarsko pakiranje z označenimi številkami dni):
English: STATEMENT OF ACTIVE SUBSTANCE Each dispersible/chewable tablet contains 5 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena disperzibilna/žvečljiva tableta vsebuje 5 mg lamotrigina.
English: STATEMENT OF ACTIVE SUBSTANCE Each dispersible/chewable tablet contains 50 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena disperzibilna/žvečljiva tableta vsebuje 50 mg lamotrigina.
English: STATEMENT OF ACTIVE SUBSTANCE Each dispersible/chewable tablet contains 200 mg lamotrigine
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE Ena <disperzibilna/žvečljiva><disperzibilna> tableta vsebuje 200 mg lamotrigina.
English: 5 mg Soluble Tablet
Slovenian: 5 mg Tableta za peroralno raztopino
English: (Starter pack 21 tablets, valproate add-on therapy - calender pack showing day numbers): 1 3 5 7 9 11 13 (one pocket)
Slovenian: (Začetno pakiranje z 21 tabletami, dodatek zdravljenja z valproatom - koledarsko pakiranje z označenimi številkami dni):
English: 25 mg Dispersible / Chewable Tablet
Slovenian: 25 mg Disperzibilna/žvečljiva tableta
English: Other information about Tredaptive:
Slovenian: Druge informacije o zdravilu Tredaptive:
English: The European Commission granted a marketing authorisation valid throughout the European Union for Tredaptive to Merck Sharp & Dohme Ltd. on 3 July 2008.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Tredaptive, veljavno po vsej Evropski uniji, odobrila družbi Merck Sharp & Dohme Ltd dne 3. julija 2008.
English: Tredaptive is not recommended for use in children under 18 years of age because of a lack of information on its safety and effectiveness in this group.
Slovenian: Zdravilo Tredaptive ni priporočeno za zdravljenje otrok, starih manj kot 18 let, saj ni zadostnih informacij o varnosti in učinkovitosti v tej skupini.
English: The tablets must be swallowed whole, and should not be split, broken, crushed or chewed.
Slovenian: Tableto je treba pogoltniti celo, ne sme se jo prelomiti, zlomiti, zdrobiti ali zgristi.
English: The starting dose of Tredaptive is one tablet once a day for four weeks, after which the dose is increased to two tablets once a day.
Slovenian: Začetni odmerek zdravila Tredaptive je ena tableta enkrat dnevno štiri tedne, nato pa se odmerek poveča na dve tableti enkrat dnevno.
English: It is taken by mouth, with food, in the evening or before going to bed.
Slovenian: Tableta se jemlje peroralno, s hrano, zvečer ali pred spanjem.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) TREDAPTIVE EPAR summary for the public
Slovenian: EVROPSKO JAVNO POROČILO O OCENI ZDRAVILA (EPAR) TREDAPTIVE Povzetek EPAR za javnost
English: The Committee recommended that Tredaptive be given marketing authorisation.
Slovenian: Odbor je priporočil, da se za zdravilo Tredaptive odobri dovoljenje za promet.
English: The effects of Tredaptive were first tested in experimental models before being studied in humans.
Slovenian: Učinki zdravila Tredaptive so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
English: What benefit has Tredaptive shown during the studies?
Slovenian: Kakšne koristi je zdravilo Tredaptive izkazalo med študijami?
English: The most common side effect with Tredaptive (seen in more than 1 patient in 10) is flushing.
Slovenian: Najpogostejši neželeni učinek zdravila Tredaptive (opažen pri več kot 1 bolniku od 10) je zardevanje.
English: Tredaptive is used on its own only in patients who cannot take statins.
Slovenian: Zdravilo Tredaptive se samostojno uporablja samo pri bolnikih, ki ne morejo jemati statina.
English: Tredaptive is a medicine containing two active substances: nicotinic acid (also known as niacin or vitamin B3) and laropiprant.
Slovenian: Tredaptive je zdravilo, ki vsebuje dve aktivni učinkovini: nikotinsko kislino (znano tudi kot niacin ali vitamin B3 ) in laropiprant.
English: Two studies looked at the effectiveness of Tredaptive in modifying blood fat levels.
Slovenian: Dve študiji sta preučevali učinkovitost zdravila Tredaptive pri uravnavanju ravni maščob v krvi.
English: What is the risk associated with Tredaptive?
Slovenian: Kakšna tveganja so povezana z zdravilom Tredaptive?
English: Patients with combined mixed dyslipidaemia have high blood levels of ‘bad' LDL cholesterol and triglycerides (a type of fat), and low levels of ‘good' HDL cholesterol.
Slovenian: Bolniki s kombinirano mešano dislipidemijo imajo v krvi visoko raven „slabega“ LDL holesterola in trigliceridov (vrsta maščobe) in nizko raven „dobrega“, HDL holesterola.
English: They included a total of 2,349 patients who were taking either Tredaptive or nicotinic acid.
Slovenian: Študiji sta vključevali vsega skupaj 2349 bolnikov, ki so jemali zdravilo Tredaptive ali nikotinsko kislino.
English: Tredaptive was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.
Slovenian: Zdravilo Tredaptive je bilo raziskano v štirih glavnih študijah pri bolnikih z hiperholesterolemijo ali mešano dislipidemijo.
English: The second study showed that the LDL cholesterol levels were further reduced when Tredaptive was taken with simvastatin (48% reduction), compared with Tredaptive alone (17% reduction) or simvastatin alone (37% reduction).
Slovenian: V drugi študiji so dokazali, da je prišlo še do večjega znižanja ravni LDL-holesterola v skupini, ki je jemala zdravilo Tredaptive skupaj s simvastatinom (48 % znižanje), v primerjavi s tisto, ki je jemala zdravilo Tredaptive samostojno (17 % znižanje) ali samo simvastatin (37 % znižanje).
English: Tredaptive is normally given together with a statin (the standard medicine used to reduce cholesterol) when the effectiveness of a statin taken alone is inadequate.
Slovenian: Zdravilo Tredaptive se navadno daje skupaj s statinom (standardno zdravilo za zniževanje holesterola), kadar statin samostojno ni dovolj učinkovit.
English: In the first study, LDL cholesterol levels were reduced by 19% in patients taking Tredaptive, compared with 1% in those taking placebo.
Slovenian: V prvi študiji so se ravni LDL pri bolnikih, ki so jemali zdravilo Tredaptive, znižale za 19 % v primerjavi z 1 % pri tistih, ki so jemali placebo.
English: Tredaptive should not be used in people who may be hypersensitive (allergic) to nicotinic acid, laropiprant or any of the other ingredients.
Slovenian: Zdravila Tredaptive ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) nikotinsko kislino, laropiprant ali katero koli drugo sestavino zdravila.
English: For the full list of all side effects reported with Tredaptive, see the Package Leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Tredaptive , glejte navodilo za uporabo.
English: Why has Tredaptive been approved?
Slovenian: Zakaj je bilo zdravilo Tredaptive odobreno?
English: In Tredaptive tablets, laropiprant is in one of the layers, and the other layer contains nicotinic acid.
Slovenian: En sloj tablet zdravila Tredaptive vsebuje laropiprant, drugi sloj pa vsebuje nikotinsko kislino.
English: The two active substances in Tredaptive, nicotinic acid and laropiprant, have different modes of action.
Slovenian: Zdravilni učinkovini v zdravilu Tredaptive, nikotinska kislina in laropiprant, imata različna načina delovanja.
English: The Committee for Medicinal Products for Human Use (CHMP) decided that Tredaptive's benefits are greater than its risks for the treatment of dyslipidaemia, particularly in patients with combined mixed dyslipidaemia and in patients with primary hypercholesterolaemia.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi zdravila Tredaptive pri zdravljenju dislipidemije, zlasti pri bolnikih s kombinirano mešano dislipidemijo in pri bolnikih s primarno hiperholesterolemijo, večje od z njim povezanih tveganj.
English: The first study compared the effectiveness of Tredaptive with that of nicotinic acid alone or placebo (a dummy treatment) in reducing the levels of LDL cholesterol in a total of 1,613 patients.
Slovenian: V prvi študiji so primerjali učinkovitost zdravila Tredaptive s samostojno nikotinsko kislino ali placebom (zdravilom brez zdravilne učinkovine) pri zniževanju ravni LDL-holesterola pri vsega skupaj 1613 bolnikih.
English: In the first and third studies, fewer patients taking Tredaptive reported moderate, severe or extreme flushing than patients taking nicotinic acid alone.
Slovenian: V prvi in tretji študiji je o zmernem, hudem ali skrajnem zardevanju poročalo manj tistih bolnikov, ki so jemali Tredaptive, kot tistih, ki so jemali samo nikotinsko kislino.
English: Tredaptive was effective in reducing the blood levels of LDL cholesterol.
Slovenian: Zdravilo Tredaptive je bilo učinkovito pri zniževanju ravni LDL-holesterola.
English: In the fourth study, flushing was seen on fewer days in patients taking Tredaptive than in those taking nicotinic acid alone.
Slovenian: V četrti študiji je bilo število dni opaženega zardevanja manjše pri tistih bolnikih, ki so jemali zdravilo Tredaptive kot pri tistih, ki so jemali samo nikotinsko kislino.
English: The full EPAR for Tredaptive can be found here.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Tredaptive je na voljo tukaj.
English: Tredaptive is used in addition to diet and exercise in patients with dyslipidaemia (abnormally high levels of fat in the blood), particularly ‘combined mixed dyslipidaemia' and ‘primary hypercholesterolaemia'.
Slovenian: Zdravilo Tredaptive se uporablja kot dodatek k prehrani in telesni vadbi pri bolnikih z dislipidemijo (nenormalno visoka raven maščobe v krvi), zlasti pri tistih s kombinirano mešano dislipidemijo in primarno hiperholesterolemijo.
English: It should be used with caution in patients who have problems with their kidneys and should not be used in patients with liver problems.
Slovenian: Pri bolnikih z ledvičnimi težavami je potrebna posebna previdnost pri uporabi zdravila Tredaptive, pri bolnikih z jetrnimi težavami pa se zdravilo Tredaptive ne sme uporabljati.
English: How has Tredaptive been studied?
Slovenian: Kako je bilo zdravilo Tredaptive raziskano?
English: The second study compared the combination of Tredaptive and simvastatin (a statin) with Tredaptive alone or simvastatin alone in 1,398 patients.
Slovenian: V drugi študiji so pri 1398 bolnikih primerjali kombinacijo zdravila Tredaptive in simvastatin (vrsta statina) s samostojnim zdravilom Tredaptive ali simvastatinom.
English: What is Tredaptive used for?
Slovenian: Za kaj se zdravilo Tredaptive uporablja?
English: How is Tredaptive used?
Slovenian: Kako se zdravilo Tredaptive uporablja?
English: What is Tredaptive?
Slovenian: Kaj je zdravilo Tredaptive?
English: How does Tredaptive work?
Slovenian: Kako zdravilo Tredaptive deluje?
English: These measures will help protect the environment.
Slovenian: S temi ukrepi boste pomagali pri varovanju okolja.
English: This may cause bleeding.
Slovenian: To lahko povzroči krvavitev.
English: - Low blood pressure.
Slovenian: - Nizek krvni tlak.
English: Ask your pharmacist how to throw away medicines you no longer use.
Slovenian: Vprašajte svojega farmacevta, kako odstraniti zdravila, ki jih ne potrebujete več.